SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-23-114270
Filing Date
2023-11-03
Accepted
2023-11-03 16:01:55
Documents
5
Effectiveness Date
2023-11-03

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm2329697d2_s3asr.htm S-3ASR 220069
2 EXHIBIT 5.1 tm2329697d2_ex5-1.htm EX-5.1 25246
3 EXHIBIT 23.1 tm2329697d2_ex23-1.htm EX-23.1 2314
4 EX-FILING FEES tm2329697d2_ex-filingfees.htm EX-FILING FEES 34515
5 GRAPHIC image_001.jpg GRAPHIC 4730
  Complete submission text file 0001104659-23-114270.txt   290025
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-275300 | Film No.: 231376228
SIC: 2835 In Vitro & In Vivo Diagnostic Substances